GlassScriptPhysician profile
Brant Turner
NPI 1104013614
$7,431.93
in general payments reported to CMS, 2019-2025
27 companies · $1,887 in 2025
The $1,887 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,971 · 2022: $932 · 2023: $1,136 · 2024: $1,506 · 2025: $1,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,528.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $2,379.19 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Abbott Laboratories | $1,358.56 | 2021-2025 | Proclaim, Eterna, Octrode |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $952.86 | 2021-2024 | Relistor |
| Boston Scientific Corporation | $550.50 | 2021-2025 | Intracept, General - Pain Management |
| Globus Medical, INC. | $321.07 | 2025 | Senza |
| Astrazeneca Pharmaceuticals LP | $220.19 | 2024-2025 | Fasenra, Breztri |
| Medtronic, INC. | $186.34 | 2023-2025 | Inceptiv, Kyphon Express II Kyphopak Tray |
| Scilex Pharmaceuticals INC. | $172.39 | 2021-2025 | Ztlido |
| Grt US Holding, INC. | $139.16 | 2021-2022 | |
| Vertos Medical, INC. | $135.21 | 2021 | |
| Biodelivery Sciences International, INC. | $121.61 | 2021 | |
| Phathom Pharmaceuticals, INC. | $119.70 | 2024 | Voquezna |
| Abiomed | $114.12 | 2024 | Impella |
| Spinal Simplicity, LLC | $82.65 | 2025 | Ha Minuteman G3-R |
| Amneal Pharmaceuticals LLC | $74.36 | 2023 | Lyvispah |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $70.91 | 2023-2025 | Roxybond |
| Averitas Pharma INC. | $61.44 | 2023-2025 | Qutenza |
| Collegium Pharmaceutical, INC. | $56.03 | 2022-2025 | Belbuca |
| Uswm, LLC | $52.29 | 2021-2022 | |
| Nevro Corp. | $49.43 | 2022-2023 | Senza |
| Virtus Pharmaceuticals LLC | $44.31 | 2021 | |
| Redhill Biopharma INC. | $40.76 | 2021 | |
| Arbor Pharmaceuticals, INC. | $35.90 | 2021 | |
| Almatica Pharma LLC | $29.40 | 2021-2023 | Gralise |
| Vertex Pharmaceuticals Incorporated | $25.18 | 2025 | |
| Nalu Medical, INC. | $23.38 | 2025 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brant Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.